Source:http://linkedlifedata.com/resource/pubmed/id/19075096
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
2
|
pubmed:dateCreated |
2009-1-23
|
pubmed:abstractText |
Premature aging (senescence) of endothelial cells might play an important role in the development and progression of hypertension and atherosclerosis. We hypothesized that bradykinin, a hormone that mediates vasoprotective effects of angiotensin-converting enzyme inhibitors, protects endothelial cells from oxidative stress-induced senescence. Bradykinin treatment (0.001 to 1 nmol/L) dose-dependently decreased senescence induced by 25 micromol/L of H(2)O(2) in cultured bovine aortic endothelial cells, as witnessed by a complete inhibition of increased senescent cell numbers and a 34% reduction of the levels of the senescence-associated cell cycle protein p21. Because H(2)O(2) induces senescence through superoxide-induced DNA damage, single-cell DNA damage was measured by comet assay. Bradykinin reduced DNA damage to control levels. The protective effect of bradykinin also resulted in a significant increase in the migration of H(2)O(2)-treated bovine aorta endothelial cells in an in vitro endothelial injury model, or "scratch" assay. The protective effect of bradykinin was abolished by the bradykinin B2 receptor antagonist HOE-140 and the NO production inhibitor N(omega)-methyl-L-arginine acetate salt. Therefore, we conclude that bradykinin protects endothelial cells from superoxide-induced senescence through bradykinin B2 receptor- and NO-mediated inhibition of DNA damage.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Adrenergic beta-Antagonists,
http://linkedlifedata.com/resource/pubmed/chemical/Bradykinin,
http://linkedlifedata.com/resource/pubmed/chemical/Cyclin-Dependent Kinase Inhibitor...,
http://linkedlifedata.com/resource/pubmed/chemical/Nitric Oxide,
http://linkedlifedata.com/resource/pubmed/chemical/Reactive Oxygen Species,
http://linkedlifedata.com/resource/pubmed/chemical/Receptor, Bradykinin B2,
http://linkedlifedata.com/resource/pubmed/chemical/Vasodilator Agents,
http://linkedlifedata.com/resource/pubmed/chemical/icatibant
|
pubmed:status |
MEDLINE
|
pubmed:month |
Feb
|
pubmed:issn |
1524-4563
|
pubmed:author | |
pubmed:issnType |
Electronic
|
pubmed:volume |
53
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
417-22
|
pubmed:meshHeading |
pubmed-meshheading:19075096-Adrenergic beta-Antagonists,
pubmed-meshheading:19075096-Animals,
pubmed-meshheading:19075096-Bradykinin,
pubmed-meshheading:19075096-Cattle,
pubmed-meshheading:19075096-Cell Aging,
pubmed-meshheading:19075096-Cell Movement,
pubmed-meshheading:19075096-Cells, Cultured,
pubmed-meshheading:19075096-Cyclin-Dependent Kinase Inhibitor p21,
pubmed-meshheading:19075096-DNA Damage,
pubmed-meshheading:19075096-Dose-Response Relationship, Drug,
pubmed-meshheading:19075096-Endothelium, Vascular,
pubmed-meshheading:19075096-Nitric Oxide,
pubmed-meshheading:19075096-Oxidative Stress,
pubmed-meshheading:19075096-Reactive Oxygen Species,
pubmed-meshheading:19075096-Receptor, Bradykinin B2,
pubmed-meshheading:19075096-Vasodilator Agents
|
pubmed:year |
2009
|
pubmed:articleTitle |
Bradykinin protects against oxidative stress-induced endothelial cell senescence.
|
pubmed:affiliation |
Department of Experimental Cardiology, AB 43, University Medical Center Groningen, Antonius Deusinglaan 1, Building 3211, 9713 AV Groningen, The Netherlands. h.oeseburg@thorax.umcg.nl
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|